Baird Medical Investment Holdings (BDMD) Raw Materials (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Raw Materials data on file, last reported at $374738.0 in Q4 2025.

• On a quarterly basis, Raw Materials rose 7.4% year-over-year to $374738.0 in Q4 2025; TTM through Dec 2025 was $374738.0, a 7.4% increase from a year earlier, with the FY2025 full-year figure at $374738.0, up 7.4% from the prior year.
• Raw Materials for Q4 2025 stood at $374738.0, up from $348910.0 in the prior quarter.
• Over the last five years, Raw Materials for BDMD reached as high as $516346.0 in Q4 2023 and fell as low as $348910.0 in Q4 2024.
• Historically, Raw Materials has averaged $413331.3 across 3 years, with a median of $374738.0 in 2025.
• Across the five-year window, Raw Materials slumped 32.43% in 2024 and advanced 7.4% in 2025, its largest moves.
• Year by year, Raw Materials stood at $516346.0 in 2023, then plunged by 32.43% to $348910.0 in 2024, then climbed by 7.4% to $374738.0 in 2025.
• Per Business Quant data, the three most recent Raw Materials figures were $374738.0 in Q4 2025, $348910.0 in Q4 2024, and $516346.0 in Q4 2023.